<DOC>
	<DOCNO>NCT00025493</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness docetaxel treat old woman metastatic breast cancer .</brief_summary>
	<brief_title>S0029 Docetaxel Treating Older Women With Metastatic Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine feasibility treat elderly woman metastatic breast cancer docetaxel . - Determine overall survival , 2-year survival , response ( confirm unconfirmed complete partial ) patient treat drug . - Determine toxicity tolerability drug patient . - Determine feasibility use standardized self-report measure comorbidity , depression , functional status elderly cancer patient . - Determine parameter clinical pharmacology drug elderly patient patient 60 year age . - Determine , preliminarily , genetic polymorphism gene expression level enzymes involved drug metabolism resistance patient treat drug . OUTLINE : Patients stratify accord age ( 70 vs 60 ) . Patients receive docetaxel IV 1 hour day 1 . Treatment repeat every 21 day absence disease progression unacceptable toxicity . Patients follow every 3 month 3 year . PROJECTED ACCRUAL : Approximately 80 patient ( 60 patient age 70 20 patient age 60 ) accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm breast cancer Distant metastatic disease confirm histology , cytology , strong clinical evidence Measurable disease No known brain CNS metastases Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 70 OR Under 60 Sex : Female Menopausal status : Not specify Performance status : Zubrod 02 Life expectancy : Not specify Hematopoietic : Absolute granulocyte count least 1,500/mm^3 Hemoglobin least 9 g/dL Platelet count least 100,000/mm^3 Hepatic : Bilirubin great upper limit normal ( ULN ) SGOT SGPT great 1.5 time ULN ( 2.0 time ULN liver metastasis present ) Alkaline phosphatase great 1.5 time ULN ( 2.0 time ULN liver metastasis present ) Renal : Creatinine great ULN Other : Not pregnant nursing Fertile patient must use effective contraception HIV negative No prior malignancy within past 5 year except adequately treat basal cell squamous cell skin cancer , carcinoma situ cervix , adequately treated stage I II cancer complete remission PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent immunotherapy breast cancer Chemotherapy : Prior adjuvant neoadjuvant chemotherapy allow Prior adjuvant taxanes allow No concurrent chemotherapy breast cancer Endocrine therapy : Prior hormonal therapy adjuvant set metastatic disease allow No concurrent hormonal therapy breast cancer Radiotherapy : No concurrent radiotherapy breast cancer Surgery : Not specify Other No 1 prior regimen advance , recurrent , metastatic disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>stage IV breast cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
</DOC>